ANI Pharmaceuticals to Present at the H.C. Wainwright Bioconnect Virtual Conference
04 January 2022 - 08:30AM
Business Wire
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP)
today announced that Nikhil Lalwani, Chief Executive Officer, and
Stephen Carey, Chief Financial Officer, will present virtually at
the H.C. Wainwright Bioconnect Conference as follows:
Date:
Monday, January 10, 2022
On Demand:
7:00 a.m. ET
Webcast:
https://journey.ct.events/view/5e7687b5-9c3a-4a19-b96c-88ad184d5c59
The webcast will be accessible on demand beginning on January
10, 2022, at 7:00 a.m. ET and archived for 90 days thereafter, via
the Company’s website at www.anipharmaceuticals.com, under the
Investors section.
About ANI
ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical
company serving patients in need by developing, manufacturing, and
marketing high quality branded and generic prescription
pharmaceutical products, including for diseases with high unmet
medical need. Our team is focused on delivering sustainable growth
by building a successful Purified Cortrophin™ Gel franchise,
strengthening our generics business with enhanced development
capability, innovation in established brands and leveraging our
North American manufacturing capabilities. For more information,
please visit our website www.anipharmaceuticals.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220103005452/en/
Investor Relations: Lisa M. Wilson, In-Site
Communications, Inc. T: 212-452-2793 E: lwilson@insitecony.com
Media: Angela Salerno-Robin dna Communications T:
212-445-8219 E: ASalerno-Robin@dna-comms.com
ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From Feb 2024 to Mar 2024
ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From Mar 2023 to Mar 2024